Historically, oral cancer has been associated with smoking and alcohol consumption and diagnosed primarily in 60- and 70-year-old men. However, recently, HPV-associated oropharyngeal cancers increased by 1.3% in women each year.
An SWHR interdisciplinary group of public health researchers and professionals, community leaders, and health care providers discussed how to improve HPV vaccine uptake.
The Value of Diagnostics within Women’s Health series in 2022 featured six public forums that sought to highlight the role of screening and diagnostics throughout a woman’s lifespan.
The Infectious Diseases Network meeting in fall 2022 covered the role of education in vaccine uptake and renewed hope for the human papillomavirus (HPV) vaccination rate in the United States.
SWHR captured insights from a closed roundtable meeting and a public forum on HPV-related disease prevention, in a new Journal of Women’s Health article, “Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.”
Many women have been hesitant or unable to attend health care visits because of the COVID-19 pandemic, leading to thousands of missed annual wellness visits, vaccinations, and cancer screenings.
At an SWHR roundtable, experts and patients identified gaps in research, clinical practice, policy, and education related to HPV-associated diseases.
Anal cancer is a rare and incredibly stigmatized disease — and the majority of cases in the U.S. occur in women.
The HPV vaccine is one of the major milestones in cancer research, displaying the great promise of cancer prevention.